EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Dental Patient Care America Inc (DPAT) fair value: what the stock is really worth

As of Sep 18, 2026: fair value of Dental Patient Care America Inc $0.04, price $0.04, upside +6.7%, quality 67 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · US · ISIN US24873V1052

DP Dental Patient Care America Inc logo Thin data Sep 24, 2026

Dental Patient Care America Inc

DPAT · US

NeutralThe stock looks roughly fairly valued with average quality.

·Fair value $0.0447 · Fairly valued (+7%)
✓Quality 67/100
!Mixed Growth (revenue YoY +19.1 %/yr)
!Loss over the last twelve months · -66.4% net margin (TTM) · fiscal year 2025 20.3%
✓Low debt · generates free cash flow
!Mixed vs. peers (5/11)
!Narrow moat 15/100
!Evidence only low, so the estimate is less certain
Watch Dental Patient Care America Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$0.3500 $0.0036 Fair Value $0.0447 Aug 2015 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range $0.0036 – $0.3500 · fair‑value band $0.0367 – $0.0570 · the $0.0419 price screens below the $0.0447 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Dental Patient Care America in your weekly email

Every Wednesday you see whether Dental Patient Care America is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Dental Patient Care America, Inc., through its subsidiaries, provides services to dentists and the dental industry.

Show more

Dental Patient Care America, Inc., through its subsidiaries, provides services to dentists and the dental industry. The company organizes dentists into a co-operative model of contractually networked dental practices, allowing member dentists to access various benefits, such as programs to purchase supplies, laboratory and operating services, insurance and employee benefits programs, opportunities for profit sharing, preferential business financing, and dental practice transition funding opportunities. It also offers various dental patient marketing programs, such as organization of member dentists into a network, which offers dental care plans to employers and groups. In addition, Dental Patient Care America, Inc. offers dental benefit plans. The company was founded in 1998 and is based in Salt Lake City, Utah.

Stock analysis

Dental Patient Care America Inc (DPAT) currently trades at $0.0419, while our model-based Fair Value estimate is $0.0447, implying the stock looks roughly 6.3% fairly valued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of $0.3700 per share, and 23 of the 24 models we run sit above the $0.0419 price.

Bear case: the Asset-Based group reads lowest at $0.0400, and 1 of the 24 models stay below the price. Evidence for this calculation is low.

Scenario range: $0.0367 (bear) to $0.0570 (bull), the price of $0.0419 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 67/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Dental Patient Care America Inc reported revenue of $2.9M in FY2025 versus $1.4M in FY2007, a compound +3.9%/yr. Reported net income was $581K in FY2025.

Key figures

Market cap $1.0M · P/S ratio 2.12 · EPS (TTM) $−0.0200 · Net margin 20.3% · Return on assets (EBIT) 50.5% · Operating margin −50.4% · Revenue growth (YoY) +51.6% · Free cash flow $660K.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).

What moves the price

The share trades about 40% below its 52-week high and 179% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at 7%, DPAT screens richer than that median.

Fair Value models

Bear $0.0367 Fair Value $0.0447 Bull $0.0570
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF $0.3900 $0.6600 $1.39 75
EPV $0.0400 $0.0500 $0.0600 74
Growth DCF $0.3700 $0.7200 $1.36 74
All 24 models by family
DCF Models
FCF DCF $0.3900 $0.6600 $1.39 75
Owner Earnings $0.3100 $0.7100 $1.49 71
5Y Revenue Exit $0.1600 $0.2500 $0.4100 71
5Y EBITDA Exit $0.1600 $0.2600 $0.4200 73
5Y P/E Exit $0.3700 $0.7700 $1.28 68
10Y Revenue Exit $0.2200 $0.3600 $0.5100 66
10Y EBITDA Exit $0.2300 $0.3700 $0.6000 67
10Y P/E Exit $0.3800 $0.7600 $1.40 61
Earnings-Based
Graham-Dodd $0.1600 $1.12 $1.56 63
Lynch FV $0.3300 $0.4700 $0.6100 61
PEG = 1.0 $0.3300 $0.4700 $0.6100 57
EPV $0.0400 $0.0500 $0.0600 74
Multiples
P/E Multiple $0.4000 $0.5300 $0.6600 63
P/S Multiple $0.3100 $0.4100 $0.5100 58
P/B Multiple $0.1800 $0.2400 $0.3000 55
EV/EBIT $0.0900 $0.1200 $0.1500 66
EV/EBITDA $0.0700 $0.1000 $0.1300 67
EV/Revenue $0.0600 $0.0900 $0.1200 53
Asset-Based
NCAV (Graham) $0.0300 $0.0400 $0.0500 55
Growth DCF
Growth DCF $0.3700 $0.7200 $1.36 74
Rev-Margin DCF $0.1600 $0.2600 $0.4200 71
Economic Profit
Residual Income $0.1900 $0.3000 $4.33 58
ROIC Compounder $0.0400 $0.0500 $0.0600 72
Growth Earnings
Growth-Adj P/E $0.4600 $0.6600 $0.8600 67

Open the full fair value analysis →

Notify me when DPAT reaches fair value

Put DPAT on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 67/100

Of which business quality 74 · Market factors (momentum, volatility) 55

Profitability 92
Margins and returns on capital today
Quality Growth 62
Are margins and returns improving?
Cashflow 81
Earnings quality: real cash, not paper profit
Fin. Strength 62
Balance sheet, leverage, solvency risk
Investment 50
Disciplined investing over empire-building
Low Volatility 36
Calm price path (market factor)
Momentum 56
Price trend over the last 3–12 months (market factor)
52W Momentum 75
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 82/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+19.1%
Revenue growth 24 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.2%
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: rate outside our plausibility band
not computed

Watch DPAT, get fair value alerts →

Compare Dental Patient Care America Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 257 stocks

Beats the industry median on 5/10 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 67 · Top 25%
Fair Value upside +7% · Above median
Profitability
Return on assets −56% · Bottom 25%
Net margin (TTM) −66% · Bottom 25%
Operating margin (TTM) −50% · Bottom 25%
Growth and dividend
Revenue growth 52% · Top 25%
Balance sheet
Debt / equity 0.39× · Above median

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/B 0.79× · Cheaper than median
P/S (TTM) 2.12× · Priciest 25%
P/FCF 1.5× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)42 · sector 33
FUTURE (revenue growth)100 · sector 29
PAST (return on equity)0 · sector 31
HEALTH (low debt)80 · sector 89
DIVIDEND (yield)0 · sector 42

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $438.12 $592.64 +35%
Fresenius SE FRE €45.57 €34.54 −24%
Dr. Sulaiman Al Habib Medical Services Group 4013 227.50 SAR 109.45 SAR −52%
IHH Healthcare Berhad, an investment holding company, 5225 8.00 MYR 4.87 MYR −39%
Tenet Healthcare Corporation THC $262.06 $399.58 +52%
DaVita Inc DVA $183.72 $255.97 +39%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹9,069 ₹2,908 −68%
Fresenius Medical Care AG FME €39.30 €71.28 +81%
Aier Eye Hospital Group 300015 ¥8.07 ¥10.86 +35%
Encompass Health Corporation EHC $122.76 $96.51 −21%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Dental Patient Care America Inc Fair Value". https://www.fairvalue-calculator.com/stock/DPAT

Frequently asked questions

Is Dental Patient Care America Inc (DPAT) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $0.0447 versus a price of $0.0419, about +7% upside (fairly valued).
What is the fair value of DPAT?
Our model-based fair value for Dental Patient Care America Inc is $0.0447 (as of Sep 24, 2026), built from audited fundamentals. The current price: $0.0419.
What is the quality score of DPAT?
Dental Patient Care America Inc has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Dental Patient Care America Inc (DPAT)?
Our model-based price target is the fair value of $0.0447 (as of Sep 24, 2026) from 24 valuation models. Cautious scenario $0.0367, optimistic scenario $0.0570. It is a calculation from audited fundamentals, not an analyst target.
What is the Dental Patient Care America Inc stock forecast for 2026?
Our models put fair value at $0.0447, about +7% upside versus a price of $0.0419 (fairly valued). Cautious scenario $0.0367, optimistic scenario $0.0570. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Dental Patient Care America Inc (DPAT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Dental Patient Care America Inc it is $0.0447 per share (as of Sep 24, 2026), against a price of $0.0419. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Dental Patient Care America Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, DPAT trades below its calculated fair value: price $0.0419, fair value $0.0447, a gap of about +7% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of DPAT?
No. The price is what the market pays today ($0.0419); the fair value is what the company's own numbers justify ($0.0447). For Dental Patient Care America Inc the two are $0.0028 per share apart. That gap is exactly why we show both numbers side by side.
How much is Dental Patient Care America Inc worth?
The market values Dental Patient Care America Inc at about $1.0M (market capitalisation, as of Sep 24, 2026). Per share that is $0.0419; our models calculate a fair value of $0.0447 per share.
What do the bullish and bearish scenarios say about DPAT?
Our models span a range for Dental Patient Care America Inc: cautious scenario $0.0367, base $0.0447, optimistic $0.0570 per share (as of Sep 24, 2026, price $0.0419). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Dental Patient Care America Inc (DPAT)?
Balance-sheet figures for Dental Patient Care America Inc (as of Sep 24, 2026): debt of 0.39 per unit of equity. They feed the Quality Score of 67/100, which measures business quality independently of the share price.
How far is DPAT from its 52-week high?
Dental Patient Care America Inc trades at $0.0419, about 40% below its 52-week high of $0.0700 and 179% above the low of $0.0150 (as of Sep 18, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0447 is for.
Which stocks are comparable to Dental Patient Care America Inc?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Dental Patient Care America Inc stock attractive at the current price?
The data as of Sep 24, 2026: price $0.0419, calculated fair value $0.0447 (+7%), Quality Score 67/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of DPAT calculated?
We run Dental Patient Care America Inc through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0447, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Dental Patient Care America Inc currently trades 7 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Dental Patient Care America Inc (DPAT)?
The closing price on Sep 18, 2026 was $0.0419. Our model-based fair value is $0.0447, about +7% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Dental Patient Care America Inc right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Dental Patient Care America Inc

How large is the market capitalisation of Dental Patient Care America Inc (DPAT)?
The market capitalisation of Dental Patient Care America Inc is $1.0M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Dental Patient Care America Inc (DPAT)?
The price-to-sales ratio of Dental Patient Care America Inc is 2.12 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Dental Patient Care America Inc (DPAT)?
Earnings per share at Dental Patient Care America Inc are $−0.0200. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Dental Patient Care America Inc (DPAT)?
The net margin of Dental Patient Care America Inc is 20.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Dental Patient Care America Inc (DPAT)?
On an EBIT basis the return on assets of Dental Patient Care America Inc is 50.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Dental Patient Care America Inc (DPAT)?
The operating margin of Dental Patient Care America Inc is −50.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Dental Patient Care America Inc (DPAT)?
Revenue at Dental Patient Care America Inc is growing +51.6% versus a year earlier (3y avg +81.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Dental Patient Care America Inc (DPAT) generate?
The free cash flow of Dental Patient Care America Inc is $660K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Dental Patient Care America Inc (DPAT) carry?
The net debt of Dental Patient Care America Inc is $66.5K (fiscal year 2025, ≈ 0.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Dental Patient Care America Inc in the live analysis

One click puts Dental Patient Care America Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.